EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 11 listopada 2024. Database contains 4918 unique substances/entries.
Filter the list
|
203-402-6
|
106-48-9
|
Acute Tox. 4 |
Details | |||
|
ACC ETHER
|
405-260-2
|
94050-51-8
|
Acute Tox. 4; Skin Sens. 1 |
Details | ||
|
203-176-9
|
104-12-1
|
Acute Tox. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1 |
Details | |||
|
203-397-0
|
106-43-4
|
Acute Tox. 4 |
Details | |||
|
204-581-3
|
122-88-3
|
Acute Tox. 4 |
Details | |||
|
CORANOL
|
420-630-3
|
83926-73-2
|
Eye Dam. 1 |
Details | ||
|
401-130-4
|
71526-07-3
|
Skin Sens. 1 |
Details | |||
|
DIAZO-A-SALICYLSULFONATE
|
404-980-4
|
124737-31-1
|
Self-react. C; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
205-855-5
|
156-43-4
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
Details | |||
|
ZOLDINE (R) MS-52
|
410-470-2
|
137796-06-6
|
Skin Corr. 1B; Skin Sens. 1 |
Details | ||
|
RO 827
|
412-090-2
|
2788-74-1
|
Acute Tox. 4; Skin Sens. 1 |
Details | ||
|
432-560-0
|
61721-07-1
|
Acute Tox. 4; Skin Corr. 1A; Skin Sens. 1 |
Details | |||
|
438-670-5
|
87199-17-5
|
Skin Sens. 1 |
Details | |||
|
217-862-0
|
1987-50-4
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
-
|
-
|
ENDE Endocrine disrupting properties (Article 57(f) - environment) |
Details | |||
|
430-840-7
|
202483-63-4
|
Skin Sens. 1 |
Details | |||
|
259-980-5
|
56073-10-0
|
Repr. 1A; Acute Tox. 1; STOT RE 1 |
Details | |||
|
204-626-7
|
123-42-2
|
Eye Irrit. 2 |
Details | |||
|
432-470-1
|
189012-93-9
|
Eye Dam. 1; Skin Sens. 1 |
Details | |||
|
223-810-8
|
4083-64-1
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1 |
Details | |||
|
608-055-8
|
27147-75-7;27459-10-5
|
R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
608-055-8
|
27147-75-7;27459-10-5
|
R Toxic for reproduction (article 57c) ENDE Endocrine disrupting properties (Article 57(f) - environment) END Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
|
430-550-0
|
1671-49-4
|
Repr. 2; Acute Tox. 4; Skin Sens. 1 |
Details | |||
|
203-512-4
|
107-70-0
|
Flam. Liq. 3; Acute Tox. 4 |
Details | |||
|
2-METHOXY-4-METHYL-6-METHYLAMINO-1,3,5-TRIAZIN; DPX-L5296; L5296
|
401-360-5
|
5248-39-5
|
Acute Tox. 4; STOT RE 2 |
Details | ||